Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders

Cited by (1,001)

Items 401–500 of 1,001

1. An Interaction between the Catechol O-Methyltransferase and Serotonin Transporter Promoter Region Polymorphisms Contributes to Tridimensional Personality Questionnaire Persistence Scores in Normal Subjects
   Jonathan Benjamin, Yamima Osher, Pesach Lichtenberg, Rachel Bachner‐Melman, Inga Gritsenko, Moshe Kotler, Robert Haim Belmaker, Vadim Valsky, Michael Drendel, Richard P. Ebstein · 2000 · Neuropsychobiology
2. COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: Evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression
   Achim Berthele, Stefan Platzer, Burkard Jochim, Henning Boecker, Andreas Büttner, Bastian Conrad, Markus J. Riemenschneider, Thomas R. Toelle · 2005 · NeuroImage
3. Genetic modeling of estrogen metabolism as a risk factor of hormone-dependent disorders
   J. Huber, Christian Schneeberger, Clemens Tempfer · 2002 · Maturitas
4. Association between Catechol-O-Methyltransferase Functional Polymorphism and Male Suicide Completers
   Ono H, Osamu Shirakawa, Hideyuki Nushida, Yasuhiro Ueno, Kiyoshi Maeda · 2004 · Neuropsychopharmacology
5. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women
   Yasuo Miyoshi, Shinzaburo Noguchi · 2003 · Biomedicine & Pharmacotherapy
6. Influence of COMT val158met Genotype on the Depressed Brain during Emotional Processing and Working Memory
   Esther Marije Opmeer, Rudie Kortekaas, Marie‐José van Tol, Nic J.A. van der Wee, Saskia Woudstra, Mark A. van Buchem, Brenda W.J.H. Penninx, Dick J. Veltman, André Aleman · 2013 · PLoS ONE
7. Association Between the Catechol-O-Methyltransferase Val158Met Polymorphism and Cocaine Dependence
   Falk W. Lohoff, Andrew E. Weller, Paul J. Bloch, Aleksandra H. Nall, Thomas N. Ferraro, Kyle Matthew Kampman, Helen M. Pettinati, David W. Oslin, Charles A. Dackis, Charles P. O’Brien et al. · 2008 · Neuropsychopharmacology
8. Association between Catechol-O-Methyltransferase Gene Polymorphisms and Wearing-Off and Dyskinesia in Parkinson’s Disease
   Miho Watanabe, Satoru Harada, T. Nakamura, Norio Ohkoshi, Kazuo Yoshizawa, A. Hayashi, S. Shoji · 2003 · Neuropsychobiology
9. Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD
   Luke John Ney, Jane Akhurst, Raimondo Bruno, Patrick A.F. Laing, Allison Jane Matthews, Kim Louise Felmingham · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
10. Genetic Influences on Smoking: Candidate Genes
    M A Rossing · 1998 · Environmental Health Perspectives
11. Effects of Catechol-O-Methyltransferase on Normal Variation in the Cognitive Function of Children
    Jennifer H. Barnett, Jon Heron, David A Goldman, Peter Brian Jones, Ke Xu · 2009 · American Journal of Psychiatry
12. Influence of COMT Gene Polymorphism on fMRI-assessed Sustained and Transient Activity during a Working Memory Task
    Cindy M. de Frias, Petter Marklund, Elias Eriksson, Anne Larsson, Lena Öman, Kristina Annerbrink, Lars Bäckman, Lars‐Göran Nilsson, Lars H Nyberg · 2009 · Journal of Cognitive Neuroscience
13. Genotype-Dependent Differences in Sleep, Vigilance, and Response to Stimulants
    Hans‐Peter Landolt · 2008 · Current Pharmaceutical Design
14. Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments
    George Bartzokis · 2011 · Frontiers in bioscience
15. Catechol-O-Methyltransferase (COMT): An Update on Its Role in Cancer, Neurological and Cardiovascular Diseases
    Pedro Bastos, Tiago M. Bernardino Gomes, Laura Virgínia Pereira Teixeira Ribeiro · 2017 · Reviews of physiology, biochemistry and pharmacology
16. Identification of 197 genetic variations in six human methyltransferase genes in the Japanese population
    Susumu Saito, Aritoshi Iida, Akihiro Sekine, Y. Miura, Takahiro Sakamoto, C. Ogawa, Saori Kawauchi, S. Higuchi, Yusuke Nakamura, Yusuke Nakamura · 2001 · Journal of Human Genetics
17. Pharmacogenomic Testing in Child and Adolescent Psychiatry: An Evidence-Based Review
    Anna M. Wehry, Laura B. Ramsey, Shane E. Dulemba, Sarah A. Mossman, Jeffrey Robert Strawn · 2018 · Current problems in pediatric and adolescent health care
18. Genetic Susceptibility to Eating Disorders: Associated Polymorphisms and Pharmacogenetic Suggestions
    Palmiero Monteleone, Mario Maj · 2008 · Pharmacogenomics
19. Catechol-O-Methyltransferase Polymorphisms Predict Opioid Consumption in Postoperative Pain
    Keith A. Candiotti, Zhe Yang, David Buric, Kris L. Arheart, Yanping Zhang, Yiliam F. Rodriguez, Melvin C. Gitlin, Enisa M. Carvalho, Isabel Jaraba, Liyong Wang · 2014 · Anesthesia & Analgesia
20. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk
    Nora L. Nock · 2006 · Carcinogenesis
21. New insights into the genetics of fibromyalgia
    Dong-Jin Park, Shin‐Seok Lee · 2017 · The Korean Journal of Internal Medicine
22. Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes
    Doug Hyun Han, Doo Byung Park, Chul Na, Baik Seok Kee, Young Sik Lee · 2004 · Psychiatry Research
23. COMT rs4680 Met is not always the ‘smart allele’: Val allele is associated with better working memory and larger hippocampal volume in healthy Chinese
    Y. Wang, J. Li, C. Chen, C. Chen, Bi Zhu, R. K. Moysis, Xuemei Lei, H. Li, Qing‐Rong Liu, Delong Xiu et al. · 2013 · Genes Brain & Behavior
24. Importance of the COMT Gene for Sex Differences in Brain Function and Predisposition to Psychiatric Disorders
    Elizabeth M. Tunbridge, Paul J. Harrison · 2010 · Current topics in behavioral neurosciences
25. Effects of dopamine‐related gene–gene interactions on working memory component processes
    Christine Stelzel, Ulrike Basten, Christian Montag, Martin Reuter, Christian J. Fiebach · 2009 · European Journal of Neuroscience
26. Association between Catechol O‐methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in Adults
    Helene Barone Halleland, Astri Johansen Lundervold, Anne Halmøy, Jan Haavik, Stefan Johansson · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
27. Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5? nuclease assay
    Guanshan Zhu, Robert H. Lipsky, Ke Xu, Sameer Ali, Thomas M. Hyde, Joel E. Kleinman, Longina A. Akhtar, Deborah C. Mash, David A Goldman · 2004 · Psychopharmacology
28. Significance of the catechol-O-methyltransferase gene polymorphism in migraine
    Mehmet Emin Erdal, Hasan Herken, Mustafa Yilmaz · 2001 · Molecular Brain Research
29. Catechol-O-Methyltransferase (COMT) Val 108/158 Metpolymorphism does not modulate executive function in children with ADHD
    Evan Taerk, Natalie Grizenko, Leila Ben Amor, Philippe Lageix, Valentin Mbékou, Rosherie Deguzman, Adam Torkamanzehi, Marina Ter-Stepanian, Chantal Baron, Ridha Joober · 2004 · BMC Medical Genetics
30. Catechol-O-Methyltransferase (COMT) Val158Met Genotype is Associated with BOLD Response as a Function of Task Characteristic
    Ulrich Ettinger, Veena Kumari, David Andrew Collier, John F. Powell, Sonija Luzi, Tanja Maria Michel, Olurotimi Zedomi, Steven Williams · 2008 · Neuropsychopharmacology
31. COMT Val158Met Genotype as a Risk Factor for Problem Behaviors in Youth
    Albaugh, Matthew D., Harder, Valerie S., Althoff, Robert R., Rettew, David C., Ehli, Erik A., Lengyel-Nelson, Timea, Davies, Gareth E., Ayer, Lynsay, Sulman, Julie, Stanger, Catherine et al. · 2010 · Journal of the American Academy of Child & Adolescent Psychiatry
32. 5-HTTLPR and COMTval158met genotype gate amygdala reactivity and habituation
    Tina B. Lonsdorf, Armita Golkar, Kara M. Lindstöm, Peter Fransson, Martin Schalling, Arne Öhman, Martin Ingvar · 2011 · Biological Psychology
33. No Association of G-Protein-Coupled Receptor Kinase 5 or β-Adrenergic Receptor Polymorphisms with Takotsubo Cardiomyopathy in a Large Australian Cohort
    Gemma Alexandra Figtree, Richard D. Bagnall, Irfan N. Abdulla et al. · 2013 · European Journal of Heart Failure
34. Age modulates the effect of COMT genotype on delay discounting behavior
    Christopher T. Smith, Charlotte A. Boettiger · 2012 · Psychopharmacology
35. Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain
    Javier Costas, Julio Sanjuán, Ramón Ramos‐Ríos, Eduardo Paz, Santiago Agra, Amparo Tolosa, Mario Páramo, Julio Brenlla, Manuel Arrojo · 2011 · Schizophrenia Research
36. Estrogen Bioactivation, Genetic Polymorphisms, and Ovarian Cancer
    Thomas A. Sellers, Joellen M. Schildkraut, V. Shane Pankratz, Robert Alan Vierkant, Zachary S. Fredericksen, Janet E. Olson, Julie M. Cunningham, William George Taylor, Mark Liebow, Carol P. McPherson et al. · 2005 · Cancer Epidemiology Biomarkers & Prevention
37. Baroreceptor Modulation of the Cardiovascular System, Pain, Consciousness, and Cognition
    Heberto Suárez-Roca, Negmeldeen F. Mamoun, Martin Ingi Sigurdsson, William D. Maixner · 2021 · Comprehensive physiology
38. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives
    G. Lelli-Chiesa, Matthew J. Kempton, Jigar Jogia, Roberto Tatarelli, Paolo Girardi, John F. Powell, David Andrew Collier, Sophia Frangou · 2010 · Psychological Medicine
39. Self-regulation and control in personality functioning
    Charles S. Carver, Michael F. Scheier · 2012 · Cambridge University Press eBooks
40. Phytochemicals Inhibit Catechol-O-Methyltransferase Activity in Cytosolic Fractions from Healthy Human Mammary Tissues: Implications for Catechol Estrogen-Induced DNA Damage
    Majorie B.M. van Duursen · 2004 · Toxicological Sciences
41. The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults
    Warren D. Taylor, Stephan L. Zuchner, Martha E. Payne, Denise F. Messer, Tracy Jill Doty, James R. MacFall, John L. Beyer, Kousik Krishnan · 2007 · Psychiatry Research Neuroimaging
42. Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence
    Andreas Heinz, David A Goldman, J�rgen Gallinat, Günter Schumann, Imke Puls · 2004 · Psychopharmacology
43. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD
    Miguel Ángel Hernán, Harvey Checkoway, R. O’Brien, Paola Costa‐Mallen, Immaculata De Vivo, Graham A. Colditz, D. J. Hunter, Karl T. Kelsey, Alberto Ascherio · 2002 · Neurology
44. Association study of MAO‐A, COMT, 5‐HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders
    Cristina Cusin, Alessandro Serretti, Enrico Lattuada, Roberta Lilli, Cristina Lorenzi, Enrico Smeraldi · 2002 · American Journal of Medical Genetics
45. Catechol-O-methyltransferase Val158Met polymorphism associates with individual differences in sleep physiologic responses to chronic sleep loss
    Goel, Namni, Banks, Siobhan, Lin, Ling, Mignot, Emmanuel, Dinges, David F. · 2011 · PLoS ONE
46. Recent molecular genetic studies and methodological issues in suicide research.
    Shih-Jen Tsai, C. Hong, Y. Liou · 2011 · Progress in Neuro-psychopharmacology and Biological Psychiatry
47. Role of COMT, 5-HT1A, and SERT genetic polymorphisms on antidepressant response to transcranial magnetic stimulation
    Alessia Malaguti, David Rossini, Adelio Lucca, Lorenzo Magri, Cristina Lorenzi, Adele Pirovano, Cristina Colombo, Enrico Smeraldi, Raffaella Zanardi · 2011 · Depression and Anxiety
48. Transcranial Direct Current Stimulation to Improve the Dysfunction of Descending Pain Modulatory System Related to Opioids in Chronic Non-cancer Pain: An Integrative Review of Neurobiology and Meta-Analysis
    Maxciel Zortéa, Letícia Ramalho, Rael Lopes Alves, Camila Fernanda da Silveira Alves, Gilberto Braulio, Iraci Lucena da Silva Torres, Felipe Fregni, Wolnei Caumo · 2019 · Frontiers in Neuroscience
49. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase
    Nabanita Mukherjee, Kenneth K. Kídd, ANDREW J. PAKSTIS, William C. Speed, Huanxi Li, Zsanett Tárnok, Csaba Barta, Sylvester L.B. Kajuna, Judith R. Kidd · 2008 · Molecular Psychiatry
50. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.
    Elizabeth I. O. Garner, Erika E Stokes, Ross Stuart Berkowitz · 2002 · PubMed
51. Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women
    Malin Bergman Jungeström, Sten Wingren · 2001 · British Journal of Cancer
52. Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele
    Franck Schürhoff, Andreı̈ Szöke, Fabien Chevalier, Isabelle Roy, Alexandre Méary, Frank Bellivier, Bruno Giros A, Marion Leboyer · 2006 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
53. Cognitive control and the COMT Val158Met polymorphism: genetic modulation of videogame training and transfer to task-switching efficiency
    Lorenza S. Colzato, Wery P. M. van den Wildenberg, Bernhard Hommel · 2013 · Psychological Research
54. The Association Between Genetic Variants in the Dopaminergic System and Posttraumatic Stress Disorder
    Lizhuo Li, Yijun Bao, Songbai He, Gang Wang, Yanlei Guan, Dexuan Ma, Pengfei Wang, Xiaolong Huang, Shanwei Tao, Dewei Zhang et al. · 2016 · Medicine
55. A Combination of Dopamine Genes Predicts Success by Professional Wall Street Traders
    Steve Sapra, Laura E. Beavin, Paul J. Zak · 2012 · PLoS ONE
56. The catechol o‐methyltransferase (COMT) val158met polymorphism modulates the association of serious life events (SLE) and impulsive aggression in female patients with borderline personality disorder (BPD)
    Stefanie Wagner, Ömür Başkaya, Nina J. Anicker, Norbert Dahmen, Klaus Lieb, A. Tadić · 2009 · Acta Psychiatrica Scandinavica
57. A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk
    Chunyan He, Rulla M. Tamimi, Susan E. Hankinson, David J. Hunter, Jiali Han · 2008 · Breast Cancer Research and Treatment
58. Dopamine Effects on Human Error Processing Depend on Catechol-O-Methyltransferase VAL158MET Genotype
    Erik Malte Mueller, Scott Makeig, Gerhard Stemmler, Jürgen Hennig, Jan Wacker · 2011 · Journal of Neuroscience
59. Catechol-O-methyltransferase (COMT) val158met Polymorphism as a Risk Factor for PTSD After Urban Violence
    Nina Leão Marques Valente, Homero Vallada, Quirino Cordeiro, Rodrigo A. Bressan, Sérgio Baxter Andreoli, Jair de Jesus Mari, Marcelo F. Mello · 2010 · Journal of Molecular Neuroscience
60. Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome
    Doron Gothelf, Fumiko Hoeft, Christine Hinard, Joachim Franz Hallmayer, John Van Dover Stoecker, Stylianos E. Antonarakis, Michael A. Morris, Allan L. Reiss · 2007 · Human Brain Mapping
61. Interactions of HIV and Drugs of Abuse
    Kurt F. Hauser, Pamela E. Knapp · 2014 · International review of neurobiology
62. An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome
    Maria Cristina Cavallini, Daniela Di Bella, Marco Catalano, Laura Bellodi · 2000 · Psychiatry Research
63. Influence of the tyrosine hydroxylase val81met polymorphism and catechol‐O‐methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
    Keizo Yoshida, Hisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, Kazuhiro Sato, Kazuyuki Inoue, Toshio Suzuki, Kunihiko Itoh, Norio Ozaki · 2007 · Human Psychopharmacology Clinical and Experimental
64. Genetically determined dopamine availability predicts disposition for depression
    Felten, Andrea, Montag, Christian, Markett, Sebastian, Walter, Nora T., Reuter, Martin · 2011 · Brain and Behavior
65. Cognitive effects of genetic variation in monoamine neurotransmitter systems: A population‐based study of COMT , MAOA , and 5HTTLPR
    Jennifer H. Barnett, Ke Xu, Jon Heron, David A Goldman, Peter Brian Jones · 2010 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
66. COMT Val158Met polymorphism interacts with stressful life events and parental warmth to influence decision making
    Qinghua He, Gui Xue, Chuansheng Chen, Zhong‐Lin Lu, Chunhui Chen, Xuemei Lei, Yuyun Liu, Jin Li, Bi Zhu, Robert K. Moyzis et al. · 2012 · Scientific Reports
67. Catechol-O-Methyltransferase Val158Met Polymorphism in Schizophrenia: Associations with Cognitive and Motor Impairment
    Silvana Galderisi, Mario Maj, Brian W Kirkpatrick, Paola Piccardi, Armida Mucci, GIORDANO INVERNIZZI, Alessandro Rossi, Stefano Pini, Antonio Vita, Paolo Cassano et al. · 2005 · Neuropsychobiology
68. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation
    Julie E. Goodman, Laran T. Jensen, Ping He, James D. Yager · 2002 · Pharmacogenetics
69. Genetic polymorphism of catechol‐O‐methyltransferase and levodopa pharmacokinetic–pharmacodynamic pattern in patients with Parkinson's disease
    Manuela Contin, Paolo Martinelli, Mirella Mochi · 2005 · Movement Disorders
70. Association of the COMT Met158 allele with trait impulsivity in healthy young adults
    Márcio Gerhardt Soeiro‐de‐Souza, Matthew S. Stanford, Danielle Soares Bio, Rodrigo Machado‐Vieira, Ricardo Alberto Moreno · 2013 · Molecular Medicine Reports
71. Genetic influence on the working memory circuitry: Behavior, structure, function and extensions to illness
    Katherine H. Karlsgodt, Peter Bachman, Anderson M. Winkler, Carrie E. Bearden, David C. Glahn · 2011 · Behavioural Brain Research
72. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia
    Jeffrey R. Bishop, James L. Reilly, Margret S.H. Harris, Shitalben Patel, Rick A. Kittles, Judith Ann Badner, Konasale M. R. Prasad, Vishwajit Laxmikant Nimgaonkar, Matcheri S. Keshavan, John A. Sweeney · 2014 · Psychopharmacology
73. Association Between Hypnotizability and the Catechol-O-Methyltransferase (COMT) Polymorphism
    Szekely, Anna, Kovacs-Nagy, Reka, Bányai, Éva I., Gősi-Greguss, Anna C., Varga, Katalin, Halmai, Zsuzsa, Ronai, Zsolt, Sasvari-Szekely, Maria · 2010 · International Journal of Clinical and Experimental Hypnosis
74. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS
    Michaelovsky, Elena, Gothelf, Doron, Korostishevsky, Michael, Frisch, Amos, Burg, Merav, Carmel, Miri, Steinberg, Tamar, Inbar, Dov, Apter, Alan, Weizman, Abraham · 2008 · The International Journal of Neuropsychopharmacology
75. Pharmacogenetics of Nicotine and Associated Smoking Behaviors
    Julie‐Anne Tanner, Meghan J. Chenoweth, Rachel Fynvola Tyndale · 2015 · Current topics in behavioral neurosciences
76. Molecular genetics in psychology and personality neuroscience: On candidate genes, genome wide scans, and new research strategies
    Christian Montag, Richard P. Ebstein, Philippe Jawinski, Sebastian A. Markett · 2020 · Neuroscience & Biobehavioral Reviews
77. Breast Cancer
    Graham A. Colditz, Heather J. Baer, TAMIMI RULLA M. · 2006
78. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia
    Chima Matsumoto, Takahiro Shinkai, Hiroko Hori · 2004 · Psychiatry Research
79. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women
    Ali Sazcı, Emel Ergül, Cem İ̇smail Küçükali, Gamze Kılıç, Güner Kaya, İhsan Kara · 2004 · Molecular Brain Research
80. Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene
    JANUSZ K. RYBAKOWSKI, Alina Borkowska, Piotr M. Czerski, Joanna Hauser · 2002 · Psychiatry Research
81. Modification of depression by COMT val158met polymorphism in children exposed to early severe psychosocial deprivation
    Stacy S. Drury, Katherine P. Theall, Anna T. Smyke, Bronya J.B. Keats, HELEN LINK EGGER, Charles A. Nelson, Nathan A. Fox, Peter J. Marshall, Charles H. Zeanah · 2010 · Child Abuse & Neglect
82. Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report
    Lynn M. Oswald, Mary Elizabeth McCaul, Leena Choi, Xioaju Yang, Gary S. Wand · 2003 · Biological Psychiatry
83. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study
    Neslihan Aygün Kocabaş, Carole Faghel, Mara Barreto, Siegfried F. Kasper, Sylvie Linotte, Julien Mendlewicz, Magali Noro, Pierre Oswald, Daniel Souery, Joseph Zohar et al. · 2010 · International Clinical Psychopharmacology
84. The COMT Val158Met polymorphism modulates working memory performance under acute stress
    Magdalena Buckert, Brigitte M. Kudielka, Martin Reuter, Christian J. Fiebach · 2012 · Psychoneuroendocrinology
85. Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine
    Ajna Hamidovic, Andrea M. Dlugos, Abraham A. Palmer, Harriet de Wit · 2010 · Psychiatric Genetics
86. COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia
    Alessandro Bertolino, Grazia Caforio, Giuseppe Blasi · 2007 · Schizophrenia Research
87. Association of the catechol-O-methyltransferase val158met polymorphism and anxiety-related traits
    Lewina O. Lee, Carol Arlene Prescott · 2013 · Psychiatric Genetics
88. Interaction of serotonergic and noradrenergic gene variants in panic disorder
    Christine Margarete Freitag, Katharina Domschke, Claudia Rothe, Yoo-Jeong Lee, Christa Hohoff, Lise Gutknecht, Philipp G. Sand, Rolf Fimmers, Klaus‐Peter Lesch, Jürgen Deckert · 2006 · Psychiatric Genetics
89. The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition
    Yacubian, J., Büchel, C. · 2009 · Neuroscience
90. No Evidence for an Effect of COMT Val158Met Genotype on Executive Function in Patients With 22q11 Deletion Syndrome
    Bronwyn Glaser, Martin Debbané, Christine Hinard, Michael A. Morris, Sophie P. Dahoun, Stylianos E. Antonarakis, Stephan Eliez M. D · 2006 · American Journal of Psychiatry
91. Genes, emotions and gut microbiota: The next frontier for the gastroenterologist
    Arturo Panduro, Ingrid Rivera‐Íñiguez, Maricruz Sepúlveda-Villegas, Sonia Román · 2017 · World Journal of Gastroenterology
92. Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease
    Lisa M. Gallicchio, Sonja I. Berndt, Meghan A. McSorley · 2006 · BMC Cancer
93. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk
    Sara Wedrén · 2003 · Carcinogenesis
94. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families
    Marina Myles‐Worsley, Hilary H Coon, Jennifer E. McDowell, Colleen A. Brenner, M. Hoff, Ben Lind, Pam Bennett, Robert Freedman, Brett A. Clementz, William Byerley · 1999 · American Journal of Medical Genetics
95. Genetic Modulation of Transcranial Direct Current Stimulation Effects on Cognition
    Wiegand, Ariane, Nieratschker, Vanessa, Plewnia, Christian · 2016 · Frontiers in Human Neuroscience
96. Genetic variation influences on the early development of reactive emotions and their regulation by attention
    Brad E. Sheese, Pascale Voelker, Michael I. Posner, Mary Klevjord Rothbart · 2009 · Cognitive Neuropsychiatry
97. Genetic variants within the dopaminergic system interact to modulate endocrine stress reactivity and recovery
    Nina Alexander, Roman Osinsky, Eva Mueller, Anja Schmitz, Sarah J. Günthert, Yvonne Kuepper, Juergen Hennig · 2010 · Behavioural Brain Research
98. COMT as a Drug Target for Cognitive Functions and Dysfunctions
    Diego Scheggia, Sara Sannino, María Luisa Scattoni, Francesco Papaleo · 2012 · CNS & Neurological Disorders - Drug Targets
99. Personality in cross-cultural perspective
    Juris G. Dragūns · 2012 · Cambridge University Press eBooks
100. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1
     Anna Secher, Jens Drachmann Bukh, Camilla Bock, Pernille Koefoed, Henrik Berg Rasmussen, Thomas Mears Werge, Lars Vedel Kessing, Erling T. Mellerup · 2009 · International Clinical Psychopharmacology